NCT01680549View on ClinicalTrials.gov

Pain Control With Total Knee Replacement

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Postoperative Pain
Interventions
DRUG

Gabapentin

Gabapentin 600mg PO pre-operatively and continued postoperatively 300 mg PO q8 hours x 3 days.

Trial Locations (1)

79430

TTUHSC Orthopaedic Surgery MS 9436, Lubbock

All Listed Sponsors
lead

Texas Tech University Health Sciences Center

OTHER

NCT01680549 - Pain Control With Total Knee Replacement | Biotech Hunter | Biotech Hunter